Af­ter two CRLs, FDA ap­proves scPhar­ma­ceu­ti­cal­s' drug-de­vice as biotech nabs $100M to fund launch

FDA has fi­nal­ly ac­cept­ed scPhar­ma­ceu­ti­cals’ prod­uct for ap­proval — and the com­pa­ny is now hunt­ing the mon­ey to push it to mar­ket.
scPhar­ma­ceu­ti­cals made a dual …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER